Resolvins and protectins: Natural pharmacophores for resolution biology
- 30 June 2010
- journal article
- review article
- Published by Elsevier BV in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 82 (4-6), 327-332
- https://doi.org/10.1016/j.plefa.2010.02.003
Abstract
No abstract availableKeywords
Funding Information
- NIH (AI068084, P50-DE016191)
This publication has 47 references indexed in Scilit:
- Airway Lipoxin A4Generation and Lipoxin A4Receptor Expression Are Decreased in Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammationNature Immunology, 2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Synthetic chemerin-derived peptides suppress inflammation through ChemR23The Journal of Experimental Medicine, 2008
- Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genusBritish Journal of Pharmacology, 2008
- Docosanoids are multifunctional regulators of neural cell integrity and fate: Significance in aging and diseaseProstaglandins, Leukotrienes & Essential Fatty Acids, 2007
- Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signalingProceedings of the National Academy of Sciences of the United States of America, 2007
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007
- Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expressionNature Immunology, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005